Topics
CME/CE
Editorial Board
DermTech adds Allan C. Halpern, M.D., to company's melanoma advisory board
Biotechnology company DermTech announced the addition of Allan C. Halpern, M.D., chief of dermatology at Memorial Sloan-Kettering Cancer Center, to its melanoma advisory board, according to The Earth Times.
La Jolla, Calif.
- Biotechnology company DermTech announced the addition of Allan C. Halpern, M.D., chief of dermatology at Memorial Sloan-Kettering Cancer Center, to its melanoma advisory board, according to The Earth Times.
DermTech is developing molecular diagnostics for the early detection of melanoma and other diseases. Dr. Halpern is a widely recognized expert in the early detection and management of melanoma in high-risk patients, the Times reports.
Related Videos
Related Content
